Compare Danaher Corporation (DHR) vs Gigacloud Technology Inc (GCT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Gigacloud Technology Inc — how do they compare? Danaher Corporation trades at $197.72 (market cap $140.88B), while Gigacloud Technology Inc trades at $35.78 (market cap $1.32B). The key difference: Danaher Corporation is far larger — about 106.7× Gigacloud Technology Inc's market cap, and Danaher Corporation pays a 0.8% dividend while Gigacloud Technology Inc pays none. Which is the better fit depends on your goals.
| DHR | GCT | |
|---|---|---|
Market Cap | $140.88B | $1.32B |
Sector | Health | Technology |
52-Week High | $242.05 | $51.80 |
52-Week Low | $161.91 | $20.26 |
Enterprise Value | $153.66B | $1.43B |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $199.05, showing minimal daily change, with a bullish technical signal supported by moving averages. The company maintains strong profitability with a 58.94% gross margin and has beaten earnings estimates for the last three quarters. Recent news highlights the acquisition of Masimo and new product launches in its SCIEX division, indicating growth initiatives. Cash flow improved in 2025 to a net inflow of $2.54 billion, though revenue growth remains modest.
The outlook is positive with a consensus price target of $211.33, representing a 6% upside, and 69% of analysts rate it a buy. Risks include slowing revenue growth, high valuation multiples, and integration challenges from acquisitions. The stock offers a dividend yield supported by stable cash flows, but investors should monitor competitive pressures in the life sciences sector.
GigaCloud Technology (GCT) trades at $35.40, up 2.88% today, showing strong momentum with consistent earnings beats and robust fundamentals. The stock exhibits a bullish technical signal with key resistance at $36 and support at $34. Recent financials reveal impressive profitability with a 10.77% net income margin and 32.14% ROE, while valuation ratios like P/E of 8.96 suggest potential undervaluation. Positive media coverage highlights growth prospects, including recognition as a 'World Growth Leader' by TIME in June 2026.
Outlook remains positive due to earnings growth and operational efficiency, but risks include market volatility and competitive pressures. Analyst consensus is bullish with 67% buy ratings, supporting upside potential if execution continues. Investors should weigh strong cash flow against sector-specific headwinds for balanced decision-making.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →
